Shares of Lemonade, Inc. (NYSE:LMND – Get Free Report) reached a new 52-week high during mid-day trading on Friday after Piper Sandler raised their price target on the stock from $18.00 to $25.00. Piper Sandler currently has a neutral rating on the stock. Lemonade traded as high as $25.59 and last traded at $24.85, with a volume of 845028 shares. The stock had previously closed at $23.77.
Several other analysts have also recently issued reports on the stock. Jefferies Financial Group cut their price target on shares of Lemonade from $15.00 to $14.00 and set an “underperform” rating on the stock in a report on Wednesday, October 9th. JMP Securities reiterated a “market outperform” rating and issued a $40.00 price target on shares of Lemonade in a research note on Tuesday, October 15th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, Lemonade currently has a consensus rating of “Hold” and a consensus target price of $21.33.
Get Our Latest Research Report on LMND
Insider Activity
Hedge Funds Weigh In On Lemonade
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Marshall Wace LLP acquired a new stake in shares of Lemonade in the 2nd quarter worth approximately $14,181,000. General Equity Holdings LP bought a new stake in shares of Lemonade in the 2nd quarter worth $5,198,000. GSA Capital Partners LLP acquired a new stake in Lemonade in the 1st quarter valued at about $3,100,000. Millennium Management LLC grew its position in Lemonade by 388.7% in the second quarter. Millennium Management LLC now owns 165,689 shares of the company’s stock worth $2,734,000 after buying an additional 131,784 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its position in shares of Lemonade by 8.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 112,938 shares of the company’s stock worth $1,853,000 after purchasing an additional 9,107 shares during the period. 80.30% of the stock is currently owned by institutional investors and hedge funds.
Lemonade Trading Up 1.6 %
The stock has a market cap of $1.72 billion, a price-to-earnings ratio of -7.94 and a beta of 1.77. The company has a fifty day simple moving average of $18.11 and a 200-day simple moving average of $17.69.
Lemonade (NYSE:LMND – Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported ($0.95) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.02) by $0.07. Lemonade had a negative net margin of 43.51% and a negative return on equity of 31.86%. The company had revenue of $136.60 million for the quarter, compared to the consensus estimate of $129.10 million. During the same period in the previous year, the business earned ($0.88) EPS. The company’s revenue was up 19.3% on a year-over-year basis. As a group, analysts anticipate that Lemonade, Inc. will post -3.04 earnings per share for the current year.
About Lemonade
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Further Reading
- Five stocks we like better than Lemonade
- Dividend Capture Strategy: What You Need to Know
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What is Put Option Volume?
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Overbought Stocks Explained: Should You Trade Them?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.